Работы, на которые ссылается эта работа
Работ: 144
Работа: New approaches of chimeric antigen receptor (CAR)-immune cell-based therapy in gastric cancer; highlight CAR-T and CAR-NK
A view on drug resistance in cancer
Neil Vasan, José Baselga, David M. Hyman
Обзорная статья2019Цитирований: 7ABIGastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Parisa Karimi, Farhad Islami, Sharmila Anandasabapathy +2
Обзорная статья2014Цитирований: 4ABIImproving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
Обзорная статья2022Цитирований: 4ABIDevelopment of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer
Bihui Cao, Manting Liu, Jingjun Huang +17
Статья2021Цитирований: 3ABIClaudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
Changsong Qi, Jifang Gong, Jian Li +23
Статья2022Цитирований: 3ABICAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu +3
Обзорная статья2022Цитирований: 3ABIThe Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain, Renier J. Brentjens, Isabelle Rivière
Обзорная статья2013Цитирований: 3ABIKilling Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Mohamed-Reda Benmebarek, Clara H. Karches, Bruno L. Cadilha +3
Обзорная статья2019Цитирований: 2ABIDevelopment of NK cell-based cancer immunotherapies through receptor engineering
Audrey Page, Nicolas Chuvin, Jenny Valladeau‐Guilemond +1
Статья2024Цитирований: 2ABIEmerging roles of circular RNAs in gastric cancer metastasis and drug resistance
Xiaolin Wang, Jiahui Zhang, Guozhen Cao +3
Обзорная статья2022Цитирований: 2ABICircRNA: A new class of targets for gastric cancer drug resistance therapy
Ying Zheng, Zhe Li, Yao Wang +4
Обзорная статья2023Цитирований: 2ABIDeciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
Jiahua Liu, Qihang Yuan, Hui Guo +3
Статья2024Цитирований: 2ABIGastric cancer treatment: recent progress and future perspectives
Wen‐Long Guan, Ye He, Rui‐Hua Xu
Обзорная статья2023Цитирований: 2ABICAR-NK cells for cancer immunotherapy: recent advances and future directions
Tianye Li, Mengke Niu, Weijiang Zhang +3
Статья2024Цитирований: 2ABICancer immunoediting: from immunosurveillance to tumor escape
Gavin P. Dunn, Allen T. Bruce, Hiroaki Ikeda +2
Обзорная статья2002Цитирований: 2ABITumour heterogeneity and the evolution of polyclonal drug resistance
Rebecca A. Burrell, Charles Swanton
Обзорная статья2014Цитирований: 2ABI